Clinical trial
Randomised Double-Blind Placebo-Controlled Phase 3 Trial of Triumeq in Amyotrophic Lateral Sclerosis
NCT05193994 is registered in ClinicalTrials.gov with Macquarie University, Australia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised Double-Blind Placebo-Controlled Phase 3 Trial of Triumeq in Amyotrophic Lateral Sclerosis
- Lead sponsor
- Macquarie University, Australia
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- February 24, 2022
- Completion date
- June 30, 2025
- Enrollment
- 419 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.